Oxytocin, vasopressin, and human social behavior (Q37511061)

20 August 2017

1 reference

title

Oxytocin, vasopressin, and human social behavior (English)

1 reference

20 August 2017

0 references

1 reference

Gregor Domes

3

0 references

author name string

Markus Heinrichs

series ordinal

1

1 reference

PubMed ID

19505497

20 August 2017

Bernadette von Dawans

series ordinal

2

1 reference

20 August 2017

6 June 2009

1 reference

Frontiers in Neuroendocrinology

20 August 2017

1 reference

20 August 2017

30

1 reference

20 August 2017

548-557

1 reference

20 August 2017

4

1 reference

Cognitive neuroscience of human social behaviour

20 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Attachment studies with borderline patients: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Normal CSF oxytocin and NPY levels in OCD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Responses to laboratory psychosocial stress in postpartum women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Suckling-induced attenuation of plasma cortisol concentrations in postpartum lactating women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Plasma oxytocin levels in female fibromyalgia syndrome patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Report of altered urinary oxytocin and AVP excretion in neglected orphans should be reconsidered.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Intranasal oxytocin in obsessive-compulsive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

CNS region-specific oxytocin receptor expression: importance in regulation of anxiety and sex behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

The neuroscience of affiliation: forging links between basic and clinical research on neuropeptides and social behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oxytocin and experimental therapeutics in autism spectrum disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oxytocin shapes the neural circuitry of trust and trust adaptation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Vasopressin--oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Plasma oxytocin levels in depression and their correlation with the temperament dimension of reward dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

fMRI reveals amygdala activation to human faces in social phobics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Reduced plasma apelin levels in patients with autistic spectrum disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oxytocin enhances the experience of attachment security

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Is Oxytocin an Anti-Schizophrenic Hormone?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

The acute effects of intranasal oxytocin administration on endocrine and sexual function in males.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Developmental consequences of oxytocin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Neuroendocrine perspectives on social attachment and love.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Sex differences in oxytocin and vasopressin: implications for autism spectrum disorders?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Integrative functions of lactational hormones in social behavior and stress management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Neuroendocrine and emotional changes in the post-partum period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oxytocin, vasopressin and sociality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oxytocin: behavioral associations and potential as a salivary biomarker

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Relationship between Plasma Profiles of Oxytocin and Adrenocorticotropic Hormone during Suckling or Breast Stimulation in Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Cerebrospinal fluid vasopressin levels: correlates with aggression and serotonin function in personality-disordered subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Evidence of dysregulated peripheral oxytocin release among depressed women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Non-peptide arginine-vasopressin antagonists: the vaptans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oxytocin in obsessive compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oxytocin enhances processing of positive versus negative emotional information in healthy male volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Effects of different kinds of couple interaction on cortisol and heart rate responses to stress in women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Intranasal oxytocin increases positive communication and reduces cortisol levels during couple conflict

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Adult attachment and social support interact to reduce psychological but not cortisol responses to stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Effects of vasopressin on event-related potential indicators of cognitive stimulus processing in young and old humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Recognition of facial affect in Borderline Personality Disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oxytocin attenuates amygdala responses to emotional faces regardless of valence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oxytocin improves "mind-reading" in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oxytocin, vasopressin, and the neurogenetics of sociality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Amygdala hyperreactivity in borderline personality disorder: implications for emotional dysregulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Intranasal oxytocin in obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Intranasal oxytocin in trichotillomania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Orally active vasopressin V1a receptor antagonist, SRX251, selectively blocks aggressive behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Early experience in humans is associated with changes in neuropeptides critical for regulating social behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Cerebrospinal fluid oxytocin concentration in schizophrenic patients does not differ from control subjects and is not changed by neuroleptic medication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oropharyngeal regulation of water balance in polydipsic schizophrenics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Social behavior functions and related anatomical characteristics of vasotocin/vasopressin systems in vertebrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oxytocin and cortisol in romantically unattached young adults: associations with bonding and psychological distress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oxytocin and autistic disorder: alterations in peptide forms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Non-peptide vasopressin V1b receptor antagonists as potential drugs for the treatment of stress-related disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Does oxytocin influence the early detection of angry and happy faces?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oxytocin increases gaze to the eye region of human faces

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oxytocin enhances the encoding of positive social memories in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oxytocin, vasopressin and pair bonding: implications for autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Cognitive-behavioral therapy for social anxiety disorder: current status and future directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Neuropeptides and social behaviour: effects of oxytocin and vasopressin in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Neuroendocrine mechanisms of stress and social interaction: implications for mental disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Effects of suckling on hypothalamic-pituitary-adrenal axis responses to psychosocial stress in postpartum lactating women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Lactation and stress: protective effects of breast-feeding in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Evidence of abnormal amygdala functioning in borderline personality disorder: a functional MRI study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Affective instability and impulsivity in personality disorder. Results of an experimental study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oxytocin levels in social anxiety disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oxytocin increases retention of social cognition in autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Influence of a "warm touch" support enhancement intervention among married couples on ambulatory blood pressure, oxytocin, alpha amylase, and cortisol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oxytocin is not a valid biomarker when measured in saliva by immunoassay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Vasopressin and Oxytocin Excite Distinct Neuronal Populations in the Central Amygdala

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Mortyn Jones Memorial Lecture. Limbic regions mediating central actions of oxytocin on the milk-ejection reflex in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

A neurobiological basis of social attachment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oxytocin — A neuropeptide for affiliation: Evidence from behavioral, receptor autoradiographic, and comparative studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

The neurobiology of attachment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Facial EMG in an anger-provoking situation: individual differences in directing anger outwards or inwards.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Brain uptake and the analgesic effect of oxytocin--its usefulness as an analgesic agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Transmission disequilibrium testing of arginine vasopressin receptor 1A (AVPR1A) polymorphisms in autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oxytocin Modulates Neural Circuitry for Social Cognition and Fear in Humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Individual differences in allocation of funds in the dictator game associated with length of the arginine vasopressin 1a receptor RS3 promoter region and correlation between RS3 length and hippocampal mRNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oxytocin increases trust in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

A genome-wide search for alleles and haplotypes associated with autism and related pervasive developmental disorders on the Faroe Islands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

The role of central oxytocin in obsessive compulsive disorder and related normal behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with Tourette's syndrome and healthy controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Apomorphine stimulation of vasopressin- and oxytocin-neurophysins. Evidence for increased oxytocinergic and decreased vasopressinergic function in schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Association between the oxytocin receptor (OXTR) gene and autism: relationship to Vineland Adaptive Behavior Scales and cognition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oxytocin during pregnancy and early postpartum: individual patterns and maternal-fetal attachment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

The implications of attachment theory and research for understanding borderline personality disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Borderline personality disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oxytocin responsivity in mothers of infants: a preliminary study of relationships with blood pressure during laboratory stress and normal ambulatory activity

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Neuropeptidergic regulation of affiliative behavior and social bonding in animals

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Cerebrospinal fluid neurophysins in affective illness and in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Localization of high-affinity binding sites for oxytocin and vasopressin in the human brain. An autoradiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Vasopressin into the preoptic area increases grooming behavior in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

The role of oxytocin in neuropsychiatric disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Genome-wide and Ordered-Subset linkage analyses provide support for autism loci on 17q and 19p with evidence of phenotypic and interlocus genetic correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Brain-fluid barriers: relevance for theoretical controversies regarding vasopressin and oxytocin memory research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Sensitivity to intranasal oxytocin in adult men with early parental separation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Fronto-limbic dysfunction in response to facial emotion in borderline personality disorder: an event-related fMRI study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Plasma oxytocin levels in autistic children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Alterations of prolyl endopeptidase activity in the plasma of children with autistic spectrum disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Impaired repression at a vasopressin promoter polymorphism underlies overexpression of vasopressin in a rat model of trait anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Phencyclidine (PCP): a dangerous drug, but useful in schizophrenia research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Involvement of the brain oxytocin system in stress coping: interactions with the hypothalamo-pituitary-adrenal axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Brain oxytocin inhibits the (re)activity of the hypothalamo-pituitary-adrenal axis in male rats: involvement of hypothalamic and limbic brain regions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Brain oxytocin inhibits basal and stress-induced activity of the hypothalamo-pituitary-adrenal axis in male and female rats: partial action within the paraventricular nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Different patterns of oxytocin, prolactin but not cortisol release during breastfeeding in women delivered by caesarean section or by the vaginal route

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Intranasal oxytocin administration attenuates the ACTH stress response in monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oxytocin control of maternal behavior. Regulation by sex steroids and offspring stimuli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Grooming behavioral effects of oxytocin. Pharmacology, ontogeny, and comparisons with other nonapeptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Clonidine decreases plasma and cerebrospinal fluid arginine vasopressin but not oxytocin in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oxytocin Attenuates Affective Evaluations of Conditioned Faces and Amygdala Activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

The influence of attachment on perceived stress and cortisol response to acute stress in women sexually abused in childhood or adolescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

A nose-brain pathway for psychotropic peptides: evidence from a brain evoked potential study with cholecystokinin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Cerebrospinal fluid corticotropin-releasing hormone, vasopressin, and oxytocin concentrations in treated patients with major depression and controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Vasopressin- and oxytocin-induced activity in the central nervous system: electrophysiological studies using in-vitro systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Antipsychotic drugs and plasma vasopressin in normals and acute schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oxytocin Makes a Face in Memory Familiar

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Post-learning intranasal oxytocin modulates human memory for facial identity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Plasma oxytocin levels and anxiety in patients with major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

AVP- and OT-neurophysins response to apomorphine and clonidine in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Effects of oxytocin and prosocial behavior on brain responses to direct and vicariously experienced pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

No stress please! Mechanisms of stress hyporesponsiveness of the maternal brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Involvement of vasopressin in affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Structure, sequence, expression, and chromosomal localization of the human V1a vasopressin receptor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

The effects of vasopressin on human facial responses related to social communication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Sex-specific influences of vasopressin on human social communication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Preliminary research on plasma oxytocin in normal cycling women: investigating emotion and interpersonal distress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oxytocin may mediate the benefits of positive social interaction and emotions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Role of efferent and afferent vagal nerve activity during reproduction: integrating function of oxytocin on metabolism and behaviour.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oxytocin as a possible mediator of SSRI-induced antidepressant effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Plasma levels of arginine vasopressin elevated in patients with major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Neuropsychological performance and plasma cortisol, arginine vasopressin and oxytocin in patients with major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Plasma arginine vasopressin and motor activity in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Facial expression recognition ability among women with borderline personality disorder: implications for emotion regulation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Genetic variation in the vasopressin receptor 1a gene (AVPR1A) associates with pair-bonding behavior in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Examination of AVPR1a as an autism susceptibility gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Detection of salivary oxytocin levels in lactating women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oxytocin attenuates stress-induced c-fos mRNA expression in specific forebrain regions associated with modulation of hypothalamo-pituitary-adrenal activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Endocrine and behavioural responses to noise stress: comparison of virgin and lactating female rats during non-disrupted maternal activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Positive association of the oxytocin receptor gene (OXTR) with autism in the Chinese Han population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Association between the arginine vasopressin 1a receptor (AVPR1a) gene and autism in a family-based study: mediation by socialization skills

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Search for autism loci by combined analysis of Autism Genetic Resource Exchange and Finnish families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Neuropeptides and social behavior: animal models relevant to autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

The neurobiology of pair bonding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

The Neurobiology of Trust

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

Oxytocin is associated with human trustworthiness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

The effects of oxytocin and vasopressin on partner preferences in male and female prairie voles (Microtus ochrogaster).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.05.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YFRNE.2009.05.005

1 reference

20 August 2017

1 reference

PubMed ID

19505497